Isoray - Innovative Brachytherapy
International Journal of Radiation Oncology Biology Physics
Is Cs-131 or I-125 or Pd-103 the “Ideal” Isotope for Prostate Boost Brachytherapy?–A Dosimetric View Point
Authors: R. Yaparpalvi, J. Rossinow, W.A. Cavanagh, W. Choi1, L. Minsky, N. Kahan1, W. Bodner, M. Garg, S. Kalnicki, C. Guha
Published: 01/11/2007

“Cesium provides everything we want for prostate brachytherapy as both a monotherapy and in combination therapy, including delivery of a high dose of radiation more quickly for high risk patients in a low dose rate ‘setting.’” 

Dr. Bernard W. Taylor, MD

Texas Oncology - Longview Cancer Center